Thierry Dervieux - Net Worth and Insider Trading

Thierry Dervieux Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thierry Dervieux owns 1 companies in total, including Exagen Inc (XGN) .

Click here to see the complete history of Thierry Dervieux’s form 4 insider trades.

Insider Ownership Summary of Thierry Dervieux

Ticker	Comapny	Transaction Date	Type of Owner
XGN	Exagen Inc	2019-09-18	Chief Scientific Officer

Thierry Dervieux Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thierry Dervieux Ownership Network

Ownership Network List of Thierry Dervieux

No Data

Ownership Network Relation of Thierry Dervieux

Thierry Dervieux Owned Company Details

What does Exagen Inc do?

Who are the key executives at Exagen Inc?

Thierry Dervieux is the Chief Scientific Officer of Exagen Inc. Other key executives at Exagen Inc include director & President and CEO John Aballi , Chief Financial Officer Kamal Adawi , and 10 percent owner Tullis Growth Fund Ii, L.p. .

Exagen Inc (XGN) Insider Trades Summary

Over the past 18 months, Thierry Dervieux made no insider transaction in Exagen Inc (XGN). Other recent insider transactions involving Exagen Inc (XGN) include a net purchase of 96,582 shares made by John Aballi , a net sale of 25,343 shares made by Kamal Adawi , and a net sale of 5,821 shares made by Mark Hazeltine .

In summary, during the past 3 months, insiders sold 12,784 shares of Exagen Inc (XGN) in total and bought 40,401 shares, with a net purchase of 27,617 shares. During the past 18 months, 64,983 shares of Exagen Inc (XGN) were sold and 130,568 shares were bought by its insiders, resulting in a net purchase of 65,585 shares.

Exagen Inc (XGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Exagen Inc Insider Transactions

No Available Data

Thierry Dervieux Mailing Address

Above is the net worth, insider trading, and ownership report for Thierry Dervieux. You might contact Thierry Dervieux via mailing address: C/o Exagen Diagnostics, Inc., 1261 Liberty Way, Vista Ca 92081.

Discussions on Thierry Dervieux

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.